Abstract
Current drug therapy strategies for the nervous system are based on the assumption that the adult central nervous system (CNS) lacks the capacity to make new nerve cells and regenerate after injury. Contrary to a long-held dogma, adult neurogenesis occurs in the adult brain and neural stem cells (NSCs) reside in the adult CNS. Neurogenesis in the adult brain is modulated in a broad range of environmental conditions, and physio- and pathological processes, as well as by trophic factors and drugs. This suggests that newborn neuronal cells of the adult brain may be involved in the functioning of the nervous system and may mediate a broad range of physio- and pathological processes, as well as the activities endogenous and exogenous factors and molecules. Hence, the confirmation that adult neurogenesis occurs in the adult brain and NSCs reside in the adult CNS force us to rethink how drugs are functioning and whether their activity may be mediated through adult neurogenesis. This will lead to the development and design of new strategies to treat neurological diseases and injuries, particularly drug therapy.
Keywords: Antidepressants, bromodeoxyuridine, neural stem cells, neurological diseases, pharmacology, trophic factors
Central Nervous System Agents in Medicinal Chemistry
Title: Adult Neurogenesis and Drug Therapy
Volume: 8 Issue: 3
Author(s): P. Taupin
Affiliation:
Keywords: Antidepressants, bromodeoxyuridine, neural stem cells, neurological diseases, pharmacology, trophic factors
Abstract: Current drug therapy strategies for the nervous system are based on the assumption that the adult central nervous system (CNS) lacks the capacity to make new nerve cells and regenerate after injury. Contrary to a long-held dogma, adult neurogenesis occurs in the adult brain and neural stem cells (NSCs) reside in the adult CNS. Neurogenesis in the adult brain is modulated in a broad range of environmental conditions, and physio- and pathological processes, as well as by trophic factors and drugs. This suggests that newborn neuronal cells of the adult brain may be involved in the functioning of the nervous system and may mediate a broad range of physio- and pathological processes, as well as the activities endogenous and exogenous factors and molecules. Hence, the confirmation that adult neurogenesis occurs in the adult brain and NSCs reside in the adult CNS force us to rethink how drugs are functioning and whether their activity may be mediated through adult neurogenesis. This will lead to the development and design of new strategies to treat neurological diseases and injuries, particularly drug therapy.
Export Options
About this article
Cite this article as:
Taupin P., Adult Neurogenesis and Drug Therapy, Central Nervous System Agents in Medicinal Chemistry 2008; 8 (3) . https://dx.doi.org/10.2174/187152408785699596
DOI https://dx.doi.org/10.2174/187152408785699596 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Na+ Channel Pharmacology and Molecular Mechanisms of Gating
Current Pharmaceutical Design Narcolepsy in Adolescents: A Review and Three Case Reports
Adolescent Psychiatry Editorial [Hot topic: An Overview on the Design, Development, Characterization and Applications of Novel Nanomedicines for Brain Targeting (Guest Editor: Eliana B. Souto)]
Current Nanoscience Exploring the Chemistry and Therapeutic Potential of Triazoles: A Comprehensive Literature Review
Mini-Reviews in Medicinal Chemistry Neuro-Transmitters in the Central Nervous System & their Implication in Learning and Memory Processes
Current Medicinal Chemistry Role of ABC Transporters in the Chemoresistance of Human Gliomas
Current Cancer Drug Targets Critical Review on the Chemical Aspects of Cannabidiol (CBD) and Harmonization of Computational Bioactivity Data
Current Medicinal Chemistry Ultrasound-Induced Blood-Brain Barrier Opening
Current Pharmaceutical Biotechnology The Stroke-Induced Blood-Brain Barrier Disruption: Current Progress of Inspection Technique, Mechanism, and Therapeutic Target
Current Neuropharmacology Therapeutic Strategy of Erythropoietin in Neurological Disorders
CNS & Neurological Disorders - Drug Targets Bhasma: Indian Perspective of Nanomedicinal Technology
Recent Patents on Nanomedicine Concurrent Use of Antiretrovirals and Anticonvulsants in Human Immunodeficiency Virus (HIV) Seropositive Patients
Current Pharmaceutical Design Machine Learning, Molecular Modeling, and QSAR Studies on Natural Products Against Alzheimer’s Disease
Current Medicinal Chemistry Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging
Current Medicinal Chemistry Alkaloids as Important Scaffolds in Therapeutic Drugs for the Treatments of Cancer, Tuberculosis, and Smoking Cessation
Current Topics in Medicinal Chemistry Sudden Unexplained Death in Infancy and Long QT Syndrome
Current Pediatric Reviews Chemical Composition and In Vitro Neuroprotective Activity of Fibre-Type Cannabis sativa L. (Hemp)
Current Bioactive Compounds Is VEGF a Key Target of Cotinine and Other Potential Therapies Against Alzheimer Disease?
Current Alzheimer Research Interactions between Ketamine and Magnesium for the Treatment of Pain: Current State of the Art
CNS & Neurological Disorders - Drug Targets Prediction of an Interaction between Bakuchiol and Acetylcholinesterase using Adaboost
Current Bioinformatics